Who is sponsoring NCT00300924?

NCT00300924 is sponsored by Diamond Headache Clinic.

What drugs are being tested in NCT00300924?

Interventions: Rizatriptan co-administered with Acetaminophen.

What is the status of NCT00300924?

NCT00300924 is currently COMPLETED.

Last reviewed 2008-05-27 · How we verify

A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.

NCT00300924 Phase 3 COMPLETED

The purpose of this study is to test an experimental drug combination of two medications currently approved by the Food and Drug Administration (FDA) for migraine headache or other pain. These are called rizatriptan given with acetaminophen.

Details

Lead sponsor	Diamond Headache Clinic
Phase	Phase 3
Status	COMPLETED
Enrolment	200
Start date	2006-03
Completion	2007-01

Conditions

Migraine

Interventions

Rizatriptan co-administered with Acetaminophen

Primary outcomes

To compare the efficacy of rizatriptan co-administered with acetaminophen to placebo, acetaminophen and rizatriptan for the acute treatment of migraine, as measured by the percentage of patients with pain relief at 2 hours.

Countries

United States